PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-Mar-2021 Page & Page and Partners continues growth with appointment of new Senior Account Director Page & Page and Partners
12-Mar-2021 Takeda Submits New Drug Application in Japan for Lanadelumab as a Preventive Treatment for Hereditary Angioedema Attacks Takeda
12-Mar-2021 PharmaLex expands France BENELUX region PharmaLex
12-Mar-2021 APEIRON's APN01 shows clinical benefits for severely ill COVID-19 patients in phase 2 trial APEIRON Biologics AG
12-Mar-2021 Relief Announces CHF 10 Million Private Placement RELIEF THERAPEUTICS Holdings AG
11-Mar-2021 LILLY RECEIVES MHRA CONDITIONAL MARKETING AUTHORISATION FOR RETSEVMO®▼ (SELPERCATINIB), THE FIRST THERAPY DEVELOPED TO TARGET RET-DRIVEN ADVANCED LUNG AND THYROID CANCERS Eli Lilly and Company
11-Mar-2021 ViiV Healthcare presents data for long-acting cabotegravir and rilpivirine for the treatment of HIV showing continued virologic suppression to 96 weeks ViiV Healthcare
11-Mar-2021 Finnish researchers introduce a nasal COVID vaccine Rokote Laboratories Finland Ltd
11-Mar-2021 Kite, a Gilead Company, to share latest scientific advances in cell therapy research at the 47th Virtual Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) Kite, a Gilead Company
11-Mar-2021 EMA issues advice on Lilly’s bamlanivimab (LY-CoV555) alone and administered together with etesevimab (LY-CoV016) for the treatment of confirmed COVID-19 in the European Union Eli Lilly and Company
11-Mar-2021 Complix Signs Global Drug Discovery and Development Agreement with I-Mab to Develop Cell Penetrating Alphabodies against Two Intracellular Immuno-oncology Targets Complix
11-Mar-2021 LILLY RECEIVES MHRA CONDITIONAL MARKETING AUTHORISATION FOR RETSEVMO®▼ (SELPERCATINIB), THE FIRST THERAPY DEVELOPED TO TARGET RET-DRIVEN ADVANCED LUNG AND THYROID CANCERS Eli Lilly and Company
11-Mar-2021 Achilles Therapeutics to Present at the American Association for Cancer Research (AACR) Annual Meeting 2021 Achilles Therapeutics
10-Mar-2021 MagForce AG enters into an Agreement with Apeiron Investment Group Ltd. to issue Convertible Notes in the total amount of EUR 2.5 million MagForce AG
10-Mar-2021 B.R.A.I.N. Biotechnology Research And Information Network AG: Resolutions of the Annual General Meeting for the Fiscal Year 2019/2020 of BRAIN AG B.R.A.I.N. Biotechnology Research And Information Network AG
10-Mar-2021 Lynne Ensor, Parexel Chair of SMi’s 4th Annual Pharmaceutical Microbiology East Coast Conference, exclusive interview released SMi Group
10-Mar-2021 Polyplus-transfection acquires Biowire to further expand into Asia-Pacific gene and cell therapy markets Polyplus-transfection® SA
10-Mar-2021 OBN Announces FOCUS Oxford Risk Management Ltd and Partners& as New OBN Corporate Sponsor OBN
10-Mar-2021 Prime Global announces launch of new technical and strategic communications consultancy, Prime Omics Prime Global
10-Mar-2021 XPRIZE and Cognizant Announce Grand Prize Winners in Pandemic Response Challenge to Restart Economies Around the World XPRIZE and Cognizant